The Fragment-Based Drug Discovery (FBDD) market is rapidly expanding, driven by the growing need for innovative and efficient drug development approaches. This method offers key advantages over traditional drug discovery methods, including enhanced chemical diversity and higher hit rates. FBDD is particularly valuable for targeting challenging proteins that are often difficult to address using conventional methods. This article explores the key drivers of the FBDD market, its segmentation, and regional insights.